News and Media

Latest news

March 2024

Inspiring Inclusion: Celebrating International Women's Day at Accord

Read More
February 2024

Accord Healthcare nominated for 'Pf 2024' award

Read More
January 2024

World Cancer Day 2024: Accord committed to helping close the gap in cancer care

Read More
December 2023

Accord wins four ‘Pharmaceutical Technology Excellence’ awards

Read More
December 2023

Accord in 2023: Watch our End of Year video

Read More
November 2023

Accord Healthcare wins ‘CSR World Leader 2023’ award

Read More
October 2023

Accord Healthcare launches Accord Animal Health

Read More
October 2023

Accord Supporting World Menopause Day 2023

Read More
May 2023

European-wide legal guidance on medicines procurement

Read More
April 2023

Pressures on the pharmaceutical industry with The Generics Bulletin

Read More
March 2023

Accord Healthcare – The Guardian Future of Healthcare - Q1 2023

Read More
February 2023

Accord Healthcare marks World Cancer Day 2023

Read More
December 2022

Accord's approach to reducing environmental impact

Read More
December 2022

Accord and IHP at Christmas

Read More
November 2022

We are delighted to be named winners at the Global Generics & Biosimilars 2022 Awards in Frankfurt.

Read More
November 2022

Thank you to everyone who attended CPHI2022

Read More
October 2022

The Times - Future of Pharma Supplement

Read More
October 2022

Innovations in Oncology

Read More
September 2022

Department of International Trade and Health and Invest Newcastle Visit Accord’s Fawdon Site

Read More
September 2022

Accord Healthcare featured in The Guardian

Read More
July 2022

Supporting IHP to Make it Better for those in Ukraine and beyond

Read More
June 2022

Accord Germany Turns 10

Read More
May 2022

Ask Accord - Peter Kelly

Read More
May 2022

BREAKING NEWS – New Partnership for Oncology Franchise

Read More

Accord Linkedin

Once more, Accord Healthcare earns a spot among the finalists at the prestigious Pf Awards, this time in the Patient Impact category. This nomination recognises our unwavering dedication to the Medicines Repurposing Programme, in collaboration with NHS England. It's a moment that underscores our commitment to pioneering new pathways in healthcare and increasing access to vital medicines for patients.

We are grateful to be shortlisted amongst an impressive array of entries. This nomination reflects our collective ambition to elevate healthcare standards, with a keen focus on enhancing quality, safety, and broadening treatment options in partnership with entities like the MHRA and NHS England.

Hats off to our Regulatory teams for their remarkable dedication and pursuit of excellence. Their pivotal contributions have been instrumental in achieving this notable recognition.

Wish us luck!


Follow us on Linkedin